FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Clinical trial NCT03977727 · COMPLETED

Trial details

NCT number: NCT03977727
Sponsor: Texas Diabetes & Endocrinology, P.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-06-11
Primary completion: 2020-03-09
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.